Refractory thyrotoxicosis induced by iodinated contrast agents treated with therapeutic plasma exchange. A case report

Journal of Clinical Apheresis

Volumn 23, Issue 2, 2008, Pages 92-95

  Pasimeni, G ^a   Caroli, F ^a   Spriano, G ^a   Antonini, M ^a   Baldelli, R ^a   Appetecchia, M ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Iodinated contrast agents; Plasmapheresis; Refractory thyrotoxicosis

Indexed keywords

IODINATED CONTRAST MEDIUM; IODIXANOL; LIOTHYRONINE; LUGOL; METHYLPREDNISOLONE; POTASSIUM PERCHLORATE; PROPRANOLOL; THIAMAZOLE; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

ADULT; ARTICLE; CASE REPORT; DRUG DOSE INCREASE; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HUMAN; LABORATORY TEST; PLASMAPHERESIS; THYROID SCINTISCANNING; THYROTOXICOSIS; TREATMENT OUTCOME; WHOLE BODY CT;

CONTRAST MEDIA; FEMALE; HUMANS; IODINE; MIDDLE AGED; PLASMAPHERESIS; THYROTOXICOSIS;

EID: 43249091070     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20161     Document Type: Article

References (19)

1. Cooper DS. Hyperthyroidism. Lancet 2003;362:459-468.
2. Fisher JN. Management of thyrotoxicosis. South Med J 2002; 95:493-505.
3. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001;344:501-509.
4. van der Molen AJ, Thomsen HS, Morcos SK. Effect of iodinated contrast media on thyroid function in adults. Eur Radiol 2004;14:902-907.
5. Weetman AP. Graves' disease. N Engl J Med 2000;343:1236-1248.
6. Glinoer D. The role of plasmapheresis in Graves' ophthalmopathy. Exp Clin Endocrinol 1991;97:328-331.
7. Bartalena L, Marcocci C, Pinchera A. Treating severe Graves' ophthalmopathy. Baillieres Clin Endocrinol Metab 1997;11:521-536.
8. Geissler D, Ogriseg M, Fill H, Wolf H. Plasmapheresis treatment in 3 simultaneously occurring autoimmune diseases: hashimoto thyroiditis with hyperthyroidism, autoimmune thrombopenia and autoimmune hemolytic anemia. Wien Klin Wochenschr 1987;99:351-355.
9. Braithwaite SS, Brooks MH, Collins S, Bermes EW. Plasmapheresis: an adjunct to medical management of severe hyperthyroidism. J Clin Apher 1986;3:119-123.
10. Binimelis J, Bassas L, Marruecos L, Rodriguez J, Domingo ML, Madoz P, Armengol S, Mangues MA, de Leiva A. Massive thyroxine intoxication: evaluation of plasma extraction. Intensive Care Med 1987;13:33-38.
11. Aghini-Lombardi F, Mariotti S, Fosella PV, Grasso L, Pinchera A, Braverman LE, Martino E. Treatment of amiodarone iodine-induced thyrotoxicosis with plasmapheresis and methimazole. J Endocrinol Invest 1993;16:823-826.
12. Fassbender WJ, Schluter S, Stracke H, Bretzel RG, Waas W, Tillmanns H. Thyroid function after iodine-containing contrast agent administration in coronary angiography: a prospective study of euthyroid patients. Z Kardiol 2001;90:751-759.
13. Chen CC, Huang WS, Huang SC, Won GS, Lin HD. Thyrotoxicosis aggravated by iodinated contrast medium: a case report. Zhonghua Yi Xue Za Zhi 1994;53:379-382.
14. Nolte W, Muller R, Siggelkow H, Emrich D, Hufner M. Prophylactic application of thyrostatic drugs during excessive iodine exposure in euthyroid patients with thyroid autonomy: a randomized study. Eur J Endocrinol 1996;134:337-341.
15. Lawrence JE, Lamm SH, Braverman LE. The use of perchlorate for the prevention of thyrotoxicosis in patients given iodine rich contrast agents. J Endocrinol Invest 1999;22:405-407.
16. Baeza A, Aguayo J, Barria M, Pineda G. Rapid preoperative preparation in hyperthyroidism. Clin Endocrinol 1991;35:439-442.
17. Li H, Okuda J, Akamizu T, Mori T. A hyperthyroid patient with Graves' disease who was strongly resistant to methimazole: investigation on possible mechanisms of the resistance. Endocrinol J 1995;42:697-704.
18. Martino E, Bartalena L, Bogazzi F, Braverman LE. The effects of amiodarone on the thyroid. Endocrinol Rev 2001;22:240-254.
19. Guvenc B, Unsal C, Gurkan E, Dincer S. Plasmapheresis in the treatment of hyperthyroidism associated with agranulocytosis: a case report. J Clin Apher 2004;19:148-150.